1. Home
  2. ADAP vs ELOG Comparison

ADAP vs ELOG Comparison

Compare ADAP & ELOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • ELOG
  • Stock Information
  • Founded
  • ADAP 2008
  • ELOG 2006
  • Country
  • ADAP United Kingdom
  • ELOG China
  • Employees
  • ADAP N/A
  • ELOG N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • ELOG Integrated Freight & Logistics
  • Sector
  • ADAP Health Care
  • ELOG Industrials
  • Exchange
  • ADAP Nasdaq
  • ELOG Nasdaq
  • Market Cap
  • ADAP 21.3M
  • ELOG 24.9M
  • IPO Year
  • ADAP 2015
  • ELOG 2025
  • Fundamental
  • Price
  • ADAP $0.06
  • ELOG $2.41
  • Analyst Decision
  • ADAP Hold
  • ELOG
  • Analyst Count
  • ADAP 6
  • ELOG 0
  • Target Price
  • ADAP $1.02
  • ELOG N/A
  • AVG Volume (30 Days)
  • ADAP 62.3M
  • ELOG 193.5K
  • Earning Date
  • ADAP 11-12-2025
  • ELOG 01-01-0001
  • Dividend Yield
  • ADAP N/A
  • ELOG N/A
  • EPS Growth
  • ADAP N/A
  • ELOG 60.00
  • EPS
  • ADAP N/A
  • ELOG 0.16
  • Revenue
  • ADAP $65,084,999.00
  • ELOG $40,041,691.00
  • Revenue This Year
  • ADAP N/A
  • ELOG N/A
  • Revenue Next Year
  • ADAP $52.35
  • ELOG N/A
  • P/E Ratio
  • ADAP N/A
  • ELOG $15.06
  • Revenue Growth
  • ADAP N/A
  • ELOG N/A
  • 52 Week Low
  • ADAP $0.04
  • ELOG $1.82
  • 52 Week High
  • ADAP $1.17
  • ELOG $3.60
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 38.42
  • ELOG N/A
  • Support Level
  • ADAP $0.06
  • ELOG N/A
  • Resistance Level
  • ADAP $0.07
  • ELOG N/A
  • Average True Range (ATR)
  • ADAP 0.01
  • ELOG 0.00
  • MACD
  • ADAP 0.01
  • ELOG 0.00
  • Stochastic Oscillator
  • ADAP 53.33
  • ELOG 0.00

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.

Share on Social Networks: